{
  "documentMetadata": {
    "title": "Brain Abscess, Post-traumatic or Post-surgical",
    "lastUpdated": "2025-02-06",
    "sourceFile": "Brain Abscess, Post-traumatic or Post-surgical.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Fever, change in mental status after head trauma or in post-neurosurgical patient.",
        "Penetrating head injury."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Staph. aureus, MRSA and MSSA",
        "Coagulase-negative staphylococci",
        "Enterobacteriaceae",
        "Pseudomonas aeruginosa",
        "Streptococci",
        "Anaerobes"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Empiric therapy pending culture results:"
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "frequency": "q8-12h"
              },
              {
                "drug": "Cefepime",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h",
                "connector": "+"
              },
              {
                "drug": "Metronidazole",
                "dose": "500 mg",
                "route": "IV",
                "frequency": "q8h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "regimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Vancomycin",
                "dose": "15-20 mg/kg",
                "frequency": "q8-12h"
              },
              {
                "drug": "Meropenem",
                "dose": "2 gm",
                "route": "IV",
                "frequency": "q8h",
                "connector": "+"
              }
            ]
          }
        },
        {
          "type": "list",
          "items": [
            "Vancomycin dosing, see Comments"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "regimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Linezolid",
            "dose": "600 mg",
            "frequency": "q12h",
            "route": "po/IV"
          }
        ],
        "notes": "instead of vancomycin as above"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Modify regimen based on results of abscess culture and susceptibility testing.",
        "Duration of therapy not well defined but 6-8 weeks is usual."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Adjust Vancomycin dosing to achieve preferred target AUC24 400-600 µg/mL x hr (see vancomycin AUC dosing calculator); alternative is trough of 15-20 µg/mL",
        "Aspiration and/or surgical drainage of the abscess is recommended for diagnosis and definitive therapy.",
        "Review articles: N Engl J Med 2014; 371:447; Clin Microbiol Infect 2017; 23:614; Semin Neurol 2019; 39: 334, Curr Opin Infect Dis. 2024; 37:211."
      ]
    }
  ]
}
